MIMS integrated


  • Provides a comprehensive knowledge base of locally approved drug information powered with internationally referenced Clinical Decision Support tools. 
  • Embedded in the clinical application system, supplying up to date drug information and interacting intelligently with the patient’s profile to maximise healthcare  professionals’ time. 
  • Provides Clinical Decision Support knowledge bases to help healthcare professionals in electronic prescribing and dispensing environments make better-informed prescribing & therapeutic choices. 
  • Enables healthcare professionals to improve the quality of patient care in the area of medication management. 
  • A fully customisable drug database that can be mapped to any hospital  formulary and integrated into a prescribing system to double up as the backbone of the inventory management process. 
  • MIMS INTEGRATED Decision Support Modules are internationally referenced & clinically reviewed. 


  1. Drug Information​
  2. Drug Interaction Alert​
  3. Drug Allergy Alert​
  4. Drug Duplicate Alert​
  5. Drug Health Issue Alert​
  6. Drug Dose Alert​
  7. Drug Lactation Alert​
  8. Drug Pregnancy Alert​
  9. Patient Med Info​
  10. Cautionary Advisory Labels​
  11. Drug Images​


DrugAlert Module

The DrugAlert module processes drug-drug interaction checks.

An interaction warning displays essential information after checking for an interaction between two drugs:

  • Severity level of interaction
  • Documentation level to support the interaction
  • Pharmacology action of each interacting drug
  • Recommended action
  • International references


  • itraconazole + phenytoin
  • warfarin + fenofibrate
  • phenytoin + carbamazepine
  • carbamazepine + chlorpromazine
  • phenytoin + diazoxide 

DrugAllergyAlert Module

The DrugAllergyAlert module enables the healthcare professional to process drug allergy checks at the point of care by comparing a patient’s drug allergy profile and the current medication regime, against the active ingredients in the medications about to be ordered. An alert is displayed to warn against a potential drug allergy. Also, generates a cross-reaction warning for allergic cross-sensitivity between drug groups is provided with international references.


  • salicylates + tartrazines
  • heparinoids + heparins
  • penicillins + cephalosporins 

DrugDuplicateAlert Module

The DrugDuplicateAlert module provides an alert if the medicine to be prescribed, dispensed or administered has an identical therapeutic function to another medicine already prescribed to the patient.


  • omeprazole + ranitidine

omeprazole (proton pump inhibitors group) and ranitidine (H2 antagonists group) are both indicated for GI ulceration.

  • Losec® + Prevacid® 

Losec® contains omeprazole and PREVACID® contains lansoprazole. Both are proton pump inhibitors. 

DrugHealthAlert Module

The DrugHealthAlert module is used in conjunction with the patient’s profile for stored medical conditions and subsequently for potential contraindications with the prescribed medication. The database currently supports ICD10 and can be cross-referenced to several standard disease classification systems worldwide. The alert returns information on the severity, the level of documentation and a description of the contraindication. All information is internationally referenced.


  • digoxin + sick sinus syndrome
  • ciclosporin + melanoma
  • ciclosporin + renal impairment 

DrugDoseAlert Module

The DrugDoseAlert module processes drug orders to check for patient suitability and for doses against recommended therapeutic ranges. The DrugDoseAlert module warns healthcare providers if the drug being prescribed to a patient is outside of the normal dosing limits. Alerts may be triggered if the dose is sub-therapeutic (below the minimum dose) or an overdose (above the maximum and/or the absolute maximum). Alerts may also be triggered based on frequency, duration, age, gender, weight or body surface area (BSA). This helps the healthcare provider and, eventually, the patient to avoid treatment failures, adverse effects and toxicities that could be life-threatening.

  • Data and information are obtained from recognised published medical literature or internationally accepted drug references.
  • Monthly updates are completed using leads from online tertiary references.
  • Applicable and can be used by related healthcare providers. 
  • Customisable user and alert interface.
  • Dose profiles are available for combination products.
  • Dose profiles may be brand, formulation or indication specific.


  • Indication based dosing: Finasteride + benign prostatic hyperplasia
  • Weight based dosing: Abciximab
  • Body surface area (BSA) based dosing: Oxaliplatin
  • Duration based dosing: Ofloxacin
  • Gender based dosing: Bicalutamide contraindicated in female 

DrugPregnancyAlert Module

The DrugPregnancyAlert module cautions the healthcare providers if the drug being prescribed to a pregnant woman is harmful to the developing foetus. Pregnancy data is principally composed of pregnancy letter categories from the US Food and Drug Administration (FDA) and/or the Australian Drug Evaluation Committee (ADEC); and may contain short comments based on literature review of current studies and guidelines. Drug safety data for women of childbearing age are also included to avoid inadvertent exposure of the foetus to an unsafe drug, especially in unplanned pregnancies.

Key characteristics:

  • Data on pregnancy letter categories are from official product information labels approved by the US FDA and/or ADEC.
  • Comments are evaluated information on drugs and pregnancy from recognised published medical literature or internationally accepted drug references.
  • Monthly updates are completed using leads from online tertiary references, and safety updates from the FDA and ADEC.
  • Pregnancy letter categories specific to the route of administration are included.
  • For drugs without assigned pregnancy letter categories, any available data from studies/guidelines/ recommendations is provided.

DrugLactationAlert Module

The DrugLactationAlert module is a tool that alerts the healthcare provider if the medicine(s) to be prescribed or administered to a mother can inhibit lactation, cause harm to the nursing mother or child, or if the drug is indicated in conditions where lactation is a contraindication. A record in the DrugLactationAlert module contains a description on the excretion of the drug into breastmilk, the effect of the drug on either the nursing mother or infant, severity of the interaction, and the precautions needed. This helps the healthcare professional and, eventually, the nursing mother to avoid adverse events and toxicities that could be life-threatening to the infant.

Key characteristics:

  • Data and information are obtained only from recognised published medical literature or internationally accepted drug references, and not from the manufacturer’s prescribing information. 
  • Regular review and updating of information and evidence contained in the database is carried out to ensure that the information is up to date. 
  • Alerts healthcare providers about the severity, references used and description of the interaction.
  • Both generic and brand names are recognised.


MIMS INTEGRATED is delivered via the FastTrack software Application Programming Interface (API). By utilising a software API the data content and decision support modules can be quickly integrated into the clinical application system. Development and testing time are reduced allowing for fast deployment to the end user.FastTrack is implemented as an XML based API which allows for a great deal of flexibility in the integration and presentation of the data within the clinical application. Functionality is provided to allow access to the DrugInfo module as well as to support the interactive modules such as DrugAlert and DrugAllergyAlert.Built for speed and ease of deployment, the FastTrack API has been designed to be the most  convenient way to deploy MIMS knowledge into your application.FastTrack is available in three versions for different platforms:

  • Windows
  • Linux
  • Macintos

Server Requirement


  • CPU: Intel® Core2 Duo 1.7GHz
  • RAM: 2 GB
  • HDD free space: 4 GB


  • CPU: Intel® i2 2.53GHz
  • RAM: 4 GB
  • HDD free space: 5 GB